ELYM

Eliem Therapeutics Inc (ELYM)

US
$ 8.465.75%

Price Chart

Key Statistics

Market Cap
$ 342.68M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
297.15K
52W High
$ 9.58
52W Low
$ 2.90
Dividend Yield
0.00%
Beta
-0.38

Technicals

50-Day MA
6.4556
200-Day MA
5.5712
52 Week High
9.58
52 Week Low
2.9

About ELYM

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders.

Employees
9
Headquarters
Wilmington, DE
CEO
Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
IMNN
Imunon Inc. Common ...
$ 1.26
203.25
OKLO
Oklo Inc.
$ 47.95
20.81
SMR
NuScale Power Corpo...
$ 29.75
17.50
ASPI
ASP Isotopes Inc. C...
$ 8.74
11.91
CCJ
Cameco Corporation ...
$ 58.80
11.34

Top Losers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 5.64
-20.00
MNSO
MINISO Group Holdin...
$ 18.31
-17.49
NVTS
Navitas Semiconduct...
$ 4.43
-14.48
TPET
Trio Petroleum Corp...
$ 1.11
-13.28
WDAY
Workday Inc. Class ...
$ 238.20
-12.50